EUVIMEDEUVIMED entdecken
Crossref

Blood‐Brain Barrier‐Penetrating Metal‐Organic Framework Antioxidant Nanozymes for Targeted Ischemic Stroke Therapy

Qing Chen, Jin Wang, Xiaoxing Xiong, Junyang Chen, Bo Wang, Haixia Yang, Jianliang Zhou, Hongping Deng, Lijuan Gu, Jian Tian iD

Advanced Healthcare Materials · 2025-10 · 14 (26)

DOI: 10.1002/adhm.202402376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.10.2024. Verfasst von Qing Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, Chin…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Metal-Organic Frameworks, Antioxidants, Ischemic Stroke. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overproduction of reactive oxygen species (ROS) during reperfusion in ischemic stroke (IS) severely impedes neuronal survival and results in high rates of morbidity and disability. The effective blood‐brain barrier (BBB) penetration and brain delivery of antioxidative agents remain the biggest challenge in treating ischemic reperfusion‐induced cerebrovascular and neural injury. In this study, a metal‐organic framework (MOF) nanozyme (MIL‐101‐NH 2 (Fe/Cu)) with ROS scavenging activities to encapsulate neuroprotective agent rapamycin is fabricated and decorating the exterior with BBB‐targeting protein ligands (transferrin), thereby realizing enhanced drug retention and controlled release within ischemic lesions for the synergistic treatment of IS. Through the receptor‐mediated transcellular pathway, the transferrin‐coated MOF nanoparticles achieved efficient transport across the BBB and targeted accumulation at the cerebral ischemic injury site of mice with middle cerebral artery occlusion/reperfusion (MCAO/R), wherein the nanocarrier exhibited catalytic activities of ROS decomposition into O 2 and H 2 O 2 ‐responsive rapamycin release. By its BBB‐targeting, antioxidative, anti‐inflammatory, and antiapoptotic properties, the MOF nanosystem addressed multiple pathological factors of IS and realized remarkable neuroprotective effects, leading to the substantial reduction of cerebral infarction volume and accelerated recovery of nerve functions in the MCAO/R mouse model. This MOF‐based nanomedicine provides valuable design principles for effective IS therapy with multi‐mechanism synergies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierMetal-Organic FrameworksAntioxidantsIschemic StrokeNanoparticlesAnimalsMiceSirolimusMaleReactive Oxygen SpeciesNeuroprotective AgentsInfarction, Middle Cerebral ArteryReperfusion InjuryMice, Inbred C57BL

Stichwörter der Autor:innen

antioxidantblood‐brain barrierischemic strokemetal‐organic frameworknanozymeneuroprotection

Substanzen

Metal-Organic FrameworksAntioxidantsSirolimusReactive Oxygen SpeciesNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
  • Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Anesthesia, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (MOE), School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
  • Department of Vascular Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

ORCID-Profile: Jian Tian

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Q., Wang, J., Xiong, X., Chen, J., Wang, B., Yang, H., Zhou, J., Deng, H., Gu, L., & Tian, J. (2025). Blood‐Brain Barrier‐Penetrating Metal‐Organic Framework Antioxidant Nanozymes for Targeted Ischemic Stroke Therapy. Advanced Healthcare Materials, 14(26). https://doi.org/10.1002/adhm.202402376

Vancouver

Chen Q, Wang J, Xiong X, Chen J, Wang B, Yang H, et al. Blood‐Brain Barrier‐Penetrating Metal‐Organic Framework Antioxidant Nanozymes for Targeted Ischemic Stroke Therapy. Advanced Healthcare Materials. 2025;14(26). doi:10.1002/adhm.202402376

BibTeX
@article{Chen2025,
  author = {Chen, Qing and Wang, Jin and Xiong, Xiaoxing and Chen, Junyang and Wang, Bo and Yang, Haixia and Zhou, Jianliang and Deng, Hongping and Gu, Lijuan and Tian, Jian},
  title = {Blood‐Brain Barrier‐Penetrating Metal‐Organic Framework Antioxidant Nanozymes for Targeted Ischemic Stroke Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {26},
  doi = {10.1002/adhm.202402376}
}
Kostenlos starten →